Lv31
370 积分 2024-02-04 加入
Updates on tau-related drug targets and potential disease-modifying therapies for Alzheimer’s disease
23天前
已完结
Posttranslational Modifications of the Tau in PHF: Phosphorylation and Ubiquitination
1个月前
已关闭
Phase I clinical study of a multi-kinase inhibitor TG02 capsule for the treatment of recurrent high-grade gliomas with failed temozolomide treatment in Chinese patients
1个月前
已完结
Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system
1个月前
已完结
Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system
1个月前
已完结
Strategies for delivering therapeutics across the blood–brain barrier
2个月前
已完结
Targeting tau degradation: a viable therapeutic approach?
2个月前
已完结
Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer’s Disease
2个月前
已完结
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice
2个月前
已完结
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice
2个月前
已关闭
皖公网安备34019202002308
